Toronto Dominion Bank’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Toronto Dominion Bank’s Portfolio RCKTW Stock Details RCKTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49	Buy	+99	New	+$1	﹤0.01%	2254

Other funds holding RCKTW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Toronto Dominion Bank's RCKTW Position: Q2 2026 in Review

Toronto Dominion Bank opened a new position in Rocket Pharmaceuticals Warrant (RCKTW) in Q2 2026: 99 shares worth $49. The stake represents ﹤0.01% of the portfolio and ranks #2254 among its holdings.

11 funds tracked by Wall St. Rank hold RCKTW as of Q2 2026.

Toronto Dominion Bank held 99 shares of Rocket Pharmaceuticals Warrant worth $49 as of Q2 2026.
Rocket Pharmaceuticals Warrant was a new Toronto Dominion Bank position in Q2 2026.
Rocket Pharmaceuticals Warrant made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #2254 holding.
11 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.